Pooja Swamy, MD
Interventional Cardiology · South Miami, FLNPI 1356570626
Payments from drug & device makers
Across 85 payments — averaging $693.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$52K
- Abiomed$5K
- Abbott$730
- Boston Scientific$259
- Cardiovascular Systems Inc.$229
- Medtronic$162
- plus $268 from 4 others
Across 2 payments — averaging $87.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abiomed$174
What the payments were for
- Travel & lodging$3,66656%
- Food & beverage$2,85743%
- Education$691%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 15 | $52,472 |
| Abiomed | 29 | $4,864 |
| Abbott | 24 | $730 |
| Boston Scientific | 2 | $259 |
| Cardiovascular Systems Inc. | 4 | $229 |
| Medtronic | 2 | $162 |
| Philips North America LLC | 2 | $130 |
| Tactile Systems Technology Inc | 4 | $75 |
| Terumo Medical Corporation | 2 | $45 |
| Edwards Lifesciences | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$4,666
- Diamondback Peripheral$214
- Coronary Orbital Atherectomy System$128
- ROTAPRO$117
How this compares
$58,984 in reported general payments places this provider in the 80th percentile of 623 interventional cardiology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 38 | $50,171 |
| JardianceEmpagliflozin | 22 | $33,785 |
| EliquisApixaban | 20 | $25,189 |
| FarxigaDapagliflozin Propanediol | 17 | $18,132 |
| Ranolazine ErRanolazine | 19 | $1,562 |
| Atorvastatin Calcium | 149 | $1,228 |
| Losartan Potassium | 90 | $913 |
| Carvedilol | 119 | $787 |
| ClopidogrelClopidogrel Bisulfate | 87 | $782 |
| Metoprolol Succinate | 71 | $769 |
| Nitroglycerin PatchNitroglycerin | 17 | $644 |
| Amlodipine Besylate | 76 | $627 |
| Spironolactone | 69 | $528 |
| Ezetimibe | 40 | $514 |
| Nitroglycerin | 24 | $385 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in South Miami
- Dominick AngiolilloJacksonville$4M
- Douglas SpriggsClearwater$3.2M
- Rakesh PrashadOcala$3.1M
- Aldo Martinez FleitesMiami Lakes$2.2M
- Rohit AminPensacola$2M
- Roberto CubedduNaples$2M
- Arthur LeeGainesville$2M
- Ruby SatpathyJacksonville$1.8M
- Santhosh MathewsBradenton$1.7M
- Pedro Martinez-ClarkMiami$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.